文献速递肝病

严重酒精相关性肝炎死亡率趋势与危险因素的Meta分析

Meta-Analysis: Mortality Trends and Risk Factors in Severe Alcohol-Associated Hepatitis.
PubMed 文献 · Aliment Pharmacol Ther · 2025-09-20

该系统评价与Meta分析纳入34项研究共1586例严重酒精相关性肝炎(sAH)患者,评估过去五十年的短期死亡率趋势。汇总死亡率28天为26.8%(95%CI:21.0%-33.5%),60天为35.1%(95%CI:28.3%-42.5%),90天为43.7%(95%CI:34.6%-53.3%)。贝叶斯分析显示28天平均死亡率从1970年代超过50%降至2000年后约25%,但按十年分组的正式分析未检测到过去四十年短期死亡率有统计学可信的改善;校正随访时间后MELD评分与死亡率显著相关。

要点

  • sAH短期死亡率高:28天26.8%、60天35.1%、90天43.7%。
  • 过去四十年短期死亡率无统计学可信改善。
  • MELD评分与死亡率显著相关,可用于风险分层。

核心结论

  • sAH短期死亡率仍高,近几十年未见改善。
  • 亟需有效疗法、优化早期肝移植患者选择及更好的预后工具。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、EMBASE和Scopus自建库至2024年2月。
  • 纳入34项报告sAH患者28、60、90天死亡率的研究,共1586例患者。
  • 采用随机效应Meta回归模型计算汇总死亡率,I2统计量评估异质性。
  • 采用贝叶斯混合效应二项模型估计死亡率概率后验分布并按日历时间序贯更新。

主要发现

  • 汇总死亡率28天为26.8%(95%CI:21.0%-33.5%)。
  • 汇总死亡率60天为35.1%(95%CI:28.3%-42.5%)。
  • 汇总死亡率90天为43.7%(95%CI:34.6%-53.3%)。
  • 死亡率随随访时间延长稳步增加,异质性显著(I2>80%)。
  • 贝叶斯累积分析显示28天平均死亡率从1970年代超过50%降至2000年后约25%,但按十年分组的正式分析未检测到过去四十年短期死亡率有统计学可信的改善。

临床怎么用

  • 临床应认识到sAH短期死亡率仍高,需积极管理。
  • MELD评分可用于sAH患者风险分层与预后评估。
  • 早期肝移植的患者选择需优化,并开发更好的预后工具辅助决策。

局限性

  • 汇总比例Meta分析存在显著异质性(I2>80%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe alcohol-associated hepatitis (sAH) is a life-threatening condition. Despite advances in clinical management, prognosis remains poor and long-term effectiveness of available therapies is uncertain. We conducted a systematic review and meta-analysis to evaluate short-term mortality (28, 60, and 90-day) trends in sAH over the past five decades. METHODS: We searched PubMed, EMBASE, and Scopus from database inception to February 2024 for studies reporting 28, 60, and 90-day mortality in patients with sAH. Pooled mortality estimates were calculated using a random-effects meta-regression model. We assessed heterogeneity using the I2 statistic and explored sources of heterogeneity through subgroup and meta-regression analyses. Separate Bayesian mixed-effects binomial models were used to estimate the posterior distribution of mortality probability, updated sequentially across calendar time. RESULTS: 34 studies comprising 1586 patients with sAH were included. Pooled mortality rates were 26.8% (95% CI: 21.0%-33.5%) at 28 days, 35.1% (95% CI: 28.3%-42.5%) at 60 days, and 43.7% (95% CI: 34.6%-53.3%) at 90 days. Mortality increased steadily with follow-up time. Substantial heterogeneity was observed, as expected in pooled proportion meta-analysis (I2 > 80%). Although cumulative Bayesian analysis showed that average 28-day mortality declined from over 50% in the 1970s to ~25% after 2000, a formal decade-based analysis indicated no statistically credible improvement in short-term mortality was detected overall in the past four decades. In multivariable models adjusting for follow-up time, the Model for End-Stage Liver Disease (MELD) score was significantly associated with mortality. CONCLUSIONS: Short-term mortality in sAH remains high and has not improved in recent decades. These findings highlight the urgent need for effective therapies, improved patient selection for early liver transplantation, and better prognostic tools to guide clinical decision-making.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Siddique MR, Haque M, Idalsoaga F, et al. Meta-Analysis: Mortality Trends and Risk Factors in Severe Alcohol-Associated Hepatitis. Aliment Pharmacol Ther. 2025. PMID: 40974371. doi:10.1111/apt.70383

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。